mosaic hexavalent influenza vaccine (FluMos-v2)
/ National Institute of Allergy and Infectious Diseases
- LARVOL DELTA
Home
Next
Prev
1 to 5
Of
5
Go to page
1
March 17, 2025
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Recruiting ➔ Active, not recruiting
Enrollment closed • Infectious Disease • Influenza • Respiratory Diseases
March 07, 2025
Evaluating the Dose, Safety, Tolerability, and Immunogenicity of Mosaic Hexavalent Influenza Vaccine VRCFLUMOS0116-00-VP (FluMos-v2) With and Without ALFQ Adjuvant in Healthy Adults
(clinicaltrials.gov)
- P1 | N=45 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
New P1 trial • Infectious Disease • Influenza • Respiratory Diseases
January 03, 2025
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Trial completion date: Dec 2024 ➔ Dec 2025 | Trial primary completion date: Dec 2024 ➔ Dec 2025
Trial completion date • Trial primary completion date • Infectious Disease • Influenza • Respiratory Diseases
April 11, 2024
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=40 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | N=24 ➔ 40
Enrollment change • Infectious Disease • Influenza • Respiratory Diseases
August 07, 2023
Trial to Evaluate the Safety, Tolerability, and Immunogenicity of a Mosaic Hexavalent Influenza Vaccine VRC-FLUMOS0116-00-VP (FluMos-v2) in Healthy Adults
(clinicaltrials.gov)
- P1 | N=24 | Recruiting | Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Not yet recruiting ➔ Recruiting
Enrollment open • Infectious Disease • Influenza • Respiratory Diseases
1 to 5
Of
5
Go to page
1